Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LYEL | CALT | OABI | ||
| Company | Lyell Immunopharma Inc | Calliditas Therapeutics Ab ADR | Omniab Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.18 | 19.86 | 4.45 | ||
| High | 2.38 | 19.97 | 4.63 | ||
| Low | 2.14 | 19.41 | 4.41 | ||
| Last | 2.33 | 19.94 | 4.56 | ||
| Change | +0.16 | +1.29 | +0.12 | ||
| % Change | +7.37% | +6.90% | +2.70% | ||
| Volume | 825,200 | 4,700 | 471,000 | ||
| 20-Day Average Volume | 950,340 | 5,805 | 545,140 | ||
| Previous Close | 2.17 | 18.65 | 4.44 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.35 | 19.71 | 4.85 | ||
| 20-Day Raw Stochastic | 28.19% | 56.28% | 14.00% | ||
| 20-Day Relative Strength | 51.22% | 48.78% | 38.17% | ||
| Weighted Alpha | -32.82 | -16.72 | +7.81 | ||
| Today's Opinion | 72% Buy | 8% Sell | 88% Sell | ||
| Previous Opinion | 64% Buy | 40% Sell | 88% Sell | ||
| Last Month's Opinion | 8% Buy | 56% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.30% since 04/24/24 | +9.56% since 04/23/24 | unch since 04/24/24 | ||
| Low | 2.11 on 04/26/24 | 17.68 on 04/29/24 | 4.40 on 04/26/24 | ||
| High | 2.53 on 04/25/24 | 20.38 on 04/25/24 | 4.63 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +6.88% since 04/01/24 | -5.09% since 03/28/24 | -14.93% since 04/01/24 | ||
| Low | 2.01 on 04/05/24 | 16.00 on 04/16/24 | 4.40 on 04/26/24 | ||
| High | 3.14 on 04/12/24 | 23.00 on 04/09/24 | 5.54 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +25.95% since 02/01/24 | -8.36% since 01/30/24 | -22.97% since 02/01/24 | ||
| Low | 1.69 on 02/09/24 | 16.00 on 04/16/24 | 4.40 on 04/26/24 | ||
| High | 3.26 on 03/04/24 | 23.36 on 03/07/24 | 6.55 on 02/27/24 | ||
| 6-Month | |||||
| %Chg | +39.52% since 11/01/23 | +22.41% since 10/30/23 | +1.11% since 11/01/23 | ||
| Low | 1.52 on 11/27/23 | 15.25 on 11/13/23 | 4.17 on 11/10/23 | ||
| High | 3.26 on 03/04/24 | 29.30 on 12/26/23 | 6.72 on 01/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 553,213 | 594,010 | 520,039 | ||
| Shares Outstanding, K | 254,937 | 29,790 | 117,126 | ||
| Annual Sales | 130,000 | 113,810,000 | 34,160,000 | ||
| Annual Net Income | -234,630,000 | -43,960,000 | -50,620,000 | ||
| Last Quarter Sales | 10,000 | 42,680,000 | 4,820,000 | ||
| Last Quarter Net Income | -52,930,000 | -1,730,000 | -14,050,000 | ||
| 60-Month Beta | -0.56 | 1.50 | -0.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 02/28/24 | -0.06 on 02/21/24 | -0.14 on 03/20/24 | ||
| Latest Earnings Date | 05/02/24 | 05/21/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||